Your diabetes shouldn't run your day. Let Omnipod® 5 manage it with you.

No more multiple daily injections and always planning your day around doses. Omnipod 5 responds to your CGM readings and automatically adjusts your insulin every 5 minutes, day and night, so you can spend less time managing diabetes and more time living your life.

Order a Free Pod Experience Kit*

Type 1 diabetes doesn't take breaks.

There are decisions to make before each meal, before every workout, and in the middle of the night. Even with a well-established routine, glucose levels can be unpredictable.

Omnipod 5 could be right for you if any of the below sounds familiar:

You're managing type 1 diabetes with multiple daily injections and want a simpler way
You're curious about pump therapy but assumed it was complicated or out of reach
You're on a tubed pump and want the freedom of going tubeless

"After years of daily injections, switching to Omnipod® was a leap into the unknown. Now, I can't imagine going back."

MEET OMNIPOD 5

No tubes. No daily injections.
Automated Insulin Delivery

Omnipod 5 is a small, waterproof^† Pod you wear directly on your body. No tubes, no multiple daily injections, no rigid schedule to plan your day around. It automates your insulin delivery around the clock, quietly handling your type 1 diabetes management.

Easy to use: Omnipod 5 users agree that it is easy to use
Wear it: Tubeless, waterproof, and discreet under clothing
Demonstrated real world results: Over 80% time in range with optimised settings¹

1. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, ≥5 bolus/day and an average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). Optimized settings: ISF x TDI ≤1500, I:C Ratio x TDI ≤350. RF-062025-00014

HOW IT WORKS

Simplifying diabetes management

Simply fill the Pod, apply it on your body, and press start to begin up to 3 days (72 hours) of insulin management. Omnipod 5 pairs with a compatible CGM sensor receiving updated glucose levels every 5 minutes and automatically adjusts your insulin around the clock using the Omnipod 5 algorithm.

Pod and sensor with Bluetooth shown without necessary adhesive

Screen image is an example, for illustrative purposes only. Pod shown without necessary adhesive. *Sensors sold separately and require a separate prescription.

By lowering Target Glucose, users in the real world got nearly 3 hours more time in range per day²

2. Forlenza G, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. Real-world data from 403 people with type 1 diabetes (T1D) aged 2+ using the Omnipod 5 System who transitioned from the 8.3 to 6.1 mmol/L Target Glucose. Each Target Glucose was used for a consecutive period of 14-90 days. Median time in Range (3.9 -10.0 mmol/L) improved +11.8% in T1D (p<0.05). Median time <3.9 mmol/L +0.23% (p<0.05). Omnipod 5 results based on users with ≥75% of days with ≥220 readings available. Insulet Data on file. 05.15.25. Study funded by Insulet. RF-042025-00013

Baseline HbA1c greater than or equal to 8% were able to improve their HbA1c by 1%³

3. Wilmot E, et al. Lancet (2026); A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) [51% HbA1c ≥ 8% (64 mmol/mol)] with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. HbA1c in participants with baseline HbA1c ≥8% improved by 1% with OP5 (8.4% MDI vs. 7.4% OP5, p<0.0001). Time below range (<70 mg/dL or <3.9mmol/L) with OP5 was non-inferior to MDI (2.27% MDI vs. 2.56% OP5, p=0.2). Study funded by Insulet.

2+ ages Cleared for children & adults³

See how Omnipod 5 works

OMNIPOD 5 PRICING

Omnipod 5 is available on the NDSS.

Omnipod® 5 is partially subsidised through the NDSS for eligible people with type 1 diabetes, helping to reduce the ongoing cost of Omnipod 5 Pods.

Meet eligibility

You must have T1D, be NDSS registered, and have a confirmed clinical need by a healthcare professional.

Complete training & paperwork

You will need to receive training from your diabetes healthcare team who will complete the required paperwork.

Choose your access pathway

Whether you have private health insurance or prefer our no lock-in subscription option, choose the pathway that's right for you.

Once you are approved and registered as an Omnipod user, pick up subsidised Pods from a community pharmacy for the applicable NDSS co-payment.

Learn more about your options

GETTING STARTED

Ready to get started?

Experience the comfort and freedom of going tubeless with a real feel, nonfunctioning Demo Pod

Order a free demo Pod* to get a feel for Omnipod in your daily routine. Experience the comfort and freedom of going tubeless. No needles, no commitment.

If you have Type 2 Diabetes please speak with your healthcare professional before you request a call as you will not be considered suitable to use Omnipod®

Indicates required field

First Name

Last Name

Type of Diabetes

Current Treatment Type

Current Sensor

Phone Number

Postal Code

Email Address

How did you hear about Omnipod®?

Preferred Contact Time

Selection 1 Morning

Selection 1 Afternoon

Selection 1 Anytime

Selection 1 I certify I am 18 years of age or older. If you are under 18, please ask your parent or guardian to complete on your behalf.

Selection 1 In order to send you Insulet updates and marketing messages and texts, to call you for marketing purposes, and to tailor our marketing content via any Insulet marketing channels (i.e. email marketing or third-party advertising platforms), we need to collect, use and disclose your personal information, including health information. We may transfer your personal information outside of Australia, to countries which may not protect your personal information in line with the Privacy Act 1988. If you tick the box you provide your express consent to this processing of your personal and health information for these purposes. Please see our Privacy Policy for more information and for information on how you can withdraw your consent.

*The Pod Experience Kit is a needle-free, non-functioning Pod. PDM/Controller is not included.

† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see Sensor manufacturer user guide for Sensor waterproof rating.

Visit https://www.omnipod.com/en-au/important/safety/information for the for complete safety information including indications, contraindications, warnings, cautions, and instructions.

References:
1. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, ≥5 bolus/day and an average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). Optimized settings: ISF x TDI ≤1500, I:C Ratio x TDI ≤350. RF-062025-00014.

2. Forlenza G, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. Real-world data from 403 people with type 1 diabetes (T1D) aged 2+ using the Omnipod 5 System who transitioned from the 8.3 to 6.1 mmol/L Target Glucose. Each Target Glucose was used for a consecutive period of 14-90 days. Median time in Range (3.9 -10.0 mmol/L) improved +11.8% in T1D (p<0.05). Median time <3.9 mmol/L +0.23% (p<0.05). Omnipod 5 results based on users with ≥75% of days with ≥220 readings available. Insulet Data on file. 05.15.25. Study funded by Insulet. RF-042025-00013

3. Wilmot E, et al. Lancet (2026); A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) [51% HbA1c ≥ 8% (64 mmol/mol)] with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. HbA1c in participants with baseline HbA1c ≥8% improved by 1% with OP5 (8.4% MDI vs. 7.4% OP5, p<0.0001). Time below range (<70 mg/dL or <3.9mmol/L) with OP5 was non-inferior to MDI (2.27% MDI vs. 2.56% OP5, p=0.2). Study funded by Insulet.